Quantitative Dynamic 18F-FDG-PET/CT Imaging Revealed Residual Lesions in Discharged COVID-19 Patients

Jijin Yao,Jing Liu,Lei Bi,Fanwei Zhang,Yiying Huang,Hong Shan,Ying Wang,Hongjun Jin

2021-01-01

Journal of Nuclear Medicine

Abstract:185 Objectives: Prior studies have documented multiple organ injuries related to COVID-19. These findings raised concerns on the impact of injuries on the health of patients discharged. We aim to identify and evaluate the minimal residual lesions as well as the critical organs by applying the 18F-FDG PET/CT dynamic modeling approach for discharged COVID-19 patients. Methods: Seven healthy volunteers (without COVID-19 infection or tumor history) completed static 18F-FDG PET/CT scan as control group 1. Dynamic 18F-FDG PET scans were performed for 19 patients including 7 discharged COVID-19 patients (COVID-19 group) and 12 non-metastatic, newly diagnosed thyroid cancer (control group 2). Dynamic 18F-FDG PET/CT scans were carried out two to three months after discharge for COVID-19 group. Dynamic scans were performed from the apex of lung to the lower margin of liver. Patlak graphic analysis (Ki calculation) based on the dynamic modeling and SUV analysis from conventional static data were performed. In addition, COVID-19 group also completed lung function test one month after discharge. Results: COVID-19 patients were consecutively recruited, consisting of four severe and three mild pneumonia cases. Figure 1A shows the time course of recovery for a representative COVID-19 patient. One patient suffered an increased 18F-FDG uptake of the lower lobe of bilateral lungs and a slightly impaired lung function. Although no significant differences were found for SUVmax between COVD-19 group and control group 1 in myocardial (p = 0.1677) and liver (p = 0.0701), the SUVmax of lungs, brain, spleen, kidney, cervical vertebrae, thoracic vertebrae, lumbar vertebrae, and pelvisacrum in the COVID-19 group were significantly higher than that in the control group 1 (p \u003c 0.05 for all; Figure 1B). Consistent with static results, the Ki values of myocardial and liver were not significantly different between COVID-19 group and control group 2. However, the Ki values of lung from severe pneumonia were significantly higher than that of mild pneumonia (p = 0.0034) and control group 2 (p = 0.0003; Figure 1C). Conclusion: Given such small number of enrolled, this preliminary study suggested that 18F-FDG PET/CT provided a reliable estimate of residual lesions and may act as a potential tool for evaluating recovery status in discharged COVID-19 subjects.\nFigure 1. Quantitative Dynamic 18F-FDG-PET/CT Imaging Revealed Residual Lesions in Discharged COVID-19 Patients A. The time course of recovery for a representative COVID-19 patient: (a) Thoracic CT scan with scattered patchy fuzzy shadows at admission. (b) Thoracic CT obtained one week later, showing diffused grid-like opacities and\nmultiple consolidation in both lungs. (c) Thoracic CT obtained on the 16th day after admission, showing multiple patchy fuzzy shadows and light consolidation in both lungs. (d-f) PET/CT images obtained eight weeks after discharge (ie. the 77th day after admission), showing obvious absorption of lesions and scattered patchy ground-glass opacities in both lower lobes (d), PET (h) and PET/CT (i), with SUVmax of 2.37± 0.06 [L] and 2.41± 0.07 [R]. (j) Maximum-intensity projection showing entire body. Red arrow: Residual lesion; Green arrow: Dissipated lesion. Day 0, the day of admission; Day 7, the 7th day after admission; Day 16, the 16th day after admission; Day 77, the 77th day after admission. B. Comparison of SUVmax between COVID-19 patients and healthy volunteers in various organs. (a) left lung; (b) right lung; (c) myocardial; (d) heart; (e) liver; (f) spleen; (g) left kidney; (h) right kidney; (i) cervical vertebrae; (j) thoracic vertebrae; (k) lumbar vertebrae; (l) pelvisacrum. C. Comparison of Ki values among severe pneumonia, mild pneumonia, and control group 2 in lung.